Search

Search Results

• Health-related quality of life based on the European Questionnaire 5D-5L utility score in patients with multidrug-resistant tuberculosis

  Oki Nugraha Putra, Nur Indah, Fristia Rif’atul Chumaidah, Telly Purnamasari, Muhammad Arif Saifudin

  2025-08-06

  https://doi.org/10.4081/monaldi.2025.3450

  1359

  PDF_EARLY VIEW: 339

• Multidrug-resistant tuberculosis in Iran: a multicenter study

  Fatemeh Khelghati, Fatemeh Nasirpour Seilakhori, Mehdi Goudarzi, Shima Malekloo, Amir Hashem Shahidi Bonjar, Hossein Goudarzi, Mohammad Javad Nasiri

  2024-01-12

  https://doi.org/10.4081/monaldi.2024.2844

  1354

  PDF: 402
• 

  Factors associated with time to sputum culture conversion of rifampicin-resistant tuberculosis patients in Klaipeda, Lithuania in 2016-2019: a cohort study

  Saulius Diktanas, Oleksandr Korotych, Yuliia Sereda, Ogtay Gozalov, Olga Rubcova, Jay Achar

  2021-01-14

  https://doi.org/10.4081/monaldi.2021.1675

  1585

  PDF: 845
• 

  Determinants, risk factors and spatial analysis of multi-drug resistant pulmonary tuberculosis in Jodhpur, India

  Nikhilesh Ladha, Pankaj Bhardwaj, Nishant Kumar Chauhan, Kikkeri Hanumantha Setty Naveen, Vijaya Lakshmi Nag, Dandabathula Giribabu

  2022-01-18

  https://doi.org/10.4081/monaldi.2022.2026

  3038

  PDF: 1884
• 

  Monitoring of hospital acquired pneumonia in patients with severe brain injury on first access to intensive neurological rehabilitation: First year of observation

  Gianfranco Beghi, Antonio De Tanti, Paolo Serafini, Chiara Bertolino, Antonietta Celentano, Graziella Taormina

  2018-05-09

  https://doi.org/10.4081/monaldi.2018.888

  2916

  PDF: 1199

• Bronchoscopic valve therapy for tuberculosis: a scoping review

  Kshitij Agarwal, Adam T. Gray, Tudor P. Toma, Valentina Luzzi, Lorenzo Corbetta

  2025-03-05

  https://doi.org/10.4081/monaldi.2025.3281

  940

  PDF: 0

• Time to sputum culture conversion as a predictor of cure in multidrug-resistant tuberculosis patients: a multicenter retrospective cohort study in Pakistan

  Abdul Wahid, Nafees Ahmad, Fahad Saleem, Amjad Khan, Asad Khan, Faiz Ullah Khan, Farman Ullah Khan

  2025-04-24

  https://doi.org/10.4081/monaldi.2025.3200

  1260

  PDF_EARLY VIEW: 343
• 

  Depression and anxiety symptoms among people with rifampicin-resistant tuberculosis receiving in-patient care in the National Pulmonology Reference Institute in Romania

  Alexandru Stoichita, Andreea Dumitrescu, Ana Ciobanu, Cristian Oancea, Fildan Petronela, Radu Dabja, Kostyantyn Dumchev, Andrei Dadu, Beatrice Mahler-Boca, Kristina Akopyan

  2021-01-14

  https://doi.org/10.4081/monaldi.2021.1704

  2422

  PDF: 1131
• 

  Factors associated with culture conversion among adults treated for pulmonary extensively drug-resistant tuberculosis during 2018-2019 in the Russian Federation: an observational cohort study

  Anastasiia Russkikh, Oleksandr Korotych, Yuliia Sereda, Anastasia Samoilova, Jay Achar, Askar Yedilbayev, Masoud Dara, Irina Vasilyeva

  2021-01-14

  https://doi.org/10.4081/monaldi.2021.1678

  1861

  PDF: 1121

• Tailored treatment for tuberculosis in transgender individuals: a call for a patient-centered approach from a large Italian cohort

  Niccolò Riccardi, Roberta Maria Antonello, Maurizio Ferrarese, Alice Repossi, Laura Saderi, Giovanni Fumagalli, Giorgio Besozzi, Giovanni Sotgiu, Luigi Codecasa

  2024-01-11

  https://doi.org/10.4081/monaldi.2024.2852

  1030

  PDF: 289

• Outcomes of bedaquiline-containing regimen in the treatment of adults with drug-resistant tuberculosis in a tertiary care center in Rajasthan

  Roshni Mary Prince, Suman Khangarot, Qazi Faizanul Haque, Anish Mittal, Ramdhan Somani, Mansha Grover

  2023-08-07

  https://doi.org/10.4081/monaldi.2023.2618

  1189

  PDF: 562
• 

  Do catastrophic costs impact treatment outcomes in people with rifampicin-resistant tuberculosis in the Republic of Moldova?

  Valeriu Plesca, Ana Ciobanu, Yuliia Sereda, Andrei Dadu

  2021-01-14

  https://doi.org/10.4081/monaldi.2021.1650

  1649

  PDF: 741

  Supplementary: 180